Drug interactions for the following drug(s)
Applies to: Testosterone 75 MG Drug Implant <> Losartan Potassium 100 MG Oral Tablet
The metabolism of Testosterone enanthate can be decreased when combined with Losartan.
Applies to: Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet <> Losartan Potassium 100 MG Oral Tablet
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Losartan.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
The risk or severity of orthostatic hypotension and syncope can be increased when Hydrochlorothiazide is combined with Duloxetine.
Applies to: Testosterone 75 MG Drug Implant <> DULoxetine 30 MG Delayed Release Oral Capsule
Duloxetine may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
Applies to: Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Hydrocodone.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Losartan Potassium 100 MG Oral Tablet
The risk or severity of orthostatic hypotension and syncope can be increased when Losartan is combined with Duloxetine.
Applies to: Testosterone 75 MG Drug Implant <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Testosterone undecanoate may increase the hypertensive activities of Mirabegron.
Applies to: Losartan Potassium 100 MG Oral Tablet <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Losartan.
Applies to: Testosterone 75 MG Drug Implant <> Testosterone 75 MG Drug Implant
Testosterone may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
The metabolism of Mirabegron can be decreased when combined with Duloxetine.
Applies to: Testosterone 75 MG Drug Implant <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
The metabolism of Testosterone enanthate can be decreased when combined with Hydrocodone.
Applies to: Myrbetriq 25 MG 24HR Extended Release Oral Tablet <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
The metabolism of Mirabegron can be decreased when combined with Hydrocodone.
Applies to: Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Mirabegron may decrease the antihypertensive activities of Valsartan.
Applies to: Testosterone 75 MG Drug Implant <> Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
The metabolism of Testosterone enanthate can be decreased when combined with Valsartan.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Testosterone 75 MG Drug Implant <> Losartan Potassium 100 MG Oral Tablet
Drug1 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug2 (rxcui = 979480, name = losartan potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to testosterone enanthate, Drug2 is resolved to losartan and interaction asserted in DrugBank between Testosterone enanthate and Losartan. Drug1 is resolved to losartan, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Losartan and Testosterone cypionate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to losartan and interaction asserted in DrugBank between Testosterone propionate and Losartan. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to losartan and interaction asserted in DrugBank between Testosterone undecanoate and Losartan. Drug1 is resolved to testosterone, Drug2 is resolved to losartan and interaction asserted in DrugBank between Testosterone and Losartan.
Applies to: Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet <> Losartan Potassium 100 MG Oral Tablet
Drug1 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979480, name = losartan potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to losartan, Drug2 is resolved to valsartan and interaction asserted in DrugBank between Losartan and Valsartan.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
Drug1 (rxcui = 596930, name = duloxetine 30 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Hydrochlorothiazide and Duloxetine. Drug1 is resolved to valsartan, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Valsartan and Duloxetine.
Applies to: Testosterone 75 MG Drug Implant <> DULoxetine 30 MG Delayed Release Oral Capsule
Drug1 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug2 (rxcui = 596930, name = duloxetine 30 MG Delayed Release Oral Capsule, tty = SCD). Drug1 is resolved to testosterone propionate, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Testosterone propionate and Duloxetine. Drug1 is resolved to testosterone, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Testosterone and Duloxetine. Drug1 is resolved to duloxetine, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Duloxetine and Testosterone cypionate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Testosterone undecanoate and Duloxetine. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Testosterone enanthate and Duloxetine.
Applies to: Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
Drug1 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1860498, name = 12 HR hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro], tty = SBD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to hydrocodone and interaction asserted in DrugBank between Hydrochlorothiazide and Hydrocodone.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Losartan Potassium 100 MG Oral Tablet
Drug1 (rxcui = 596930, name = duloxetine 30 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 979480, name = losartan potassium 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to losartan, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Losartan and Duloxetine.
Applies to: Testosterone 75 MG Drug Implant <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug2 (rxcui = 1300797, name = 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], tty = SBD). Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Testosterone undecanoate and Mirabegron. Drug1 is resolved to testosterone, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Testosterone and Mirabegron. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Testosterone cypionate and Mirabegron. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Testosterone enanthate and Mirabegron. Drug1 is resolved to testosterone propionate, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Testosterone propionate and Mirabegron.
Applies to: Losartan Potassium 100 MG Oral Tablet <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 979480, name = losartan potassium 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1300797, name = 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], tty = SBD). Drug1 is resolved to losartan, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Losartan and Mirabegron.
Applies to: Testosterone 75 MG Drug Implant <> Testosterone 75 MG Drug Implant
Drug1 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug2 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug1 is resolved to testosterone, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone and Testosterone undecanoate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone propionate and Testosterone enanthate. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone enanthate and Testosterone propionate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone propionate and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone cypionate and Testosterone propionate. Drug1 is resolved to testosterone, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone cypionate and Testosterone. Drug1 is resolved to testosterone, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone and Testosterone enanthate. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone enanthate and Testosterone. Drug1 is resolved to testosterone, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone and Testosterone propionate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Testosterone propionate and Testosterone. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone enanthate and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone cypionate and Testosterone enanthate. Drug1 is resolved to testosterone enanthate, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone enanthate and Testosterone undecanoate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone enanthate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone cypionate. Drug1 is resolved to testosterone cypionate, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone cypionate and Testosterone undecanoate. Drug1 is resolved to testosterone propionate, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Testosterone propionate and Testosterone undecanoate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Testosterone undecanoate and Testosterone propionate.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 596930, name = duloxetine 30 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 1300797, name = 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], tty = SBD). Drug1 is resolved to duloxetine, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Duloxetine and Mirabegron.
Applies to: Testosterone 75 MG Drug Implant <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
Drug1 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug2 (rxcui = 1860498, name = 12 HR hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro], tty = SBD). Drug1 is resolved to hydrocodone, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Hydrocodone and Testosterone enanthate. Drug1 is resolved to hydrocodone, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Hydrocodone and Testosterone cypionate. Drug1 is resolved to hydrocodone, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Hydrocodone and Testosterone undecanoate.
Applies to: Myrbetriq 25 MG 24HR Extended Release Oral Tablet <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
Drug1 (rxcui = 1300797, name = 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], tty = SBD). Drug2 (rxcui = 1860498, name = 12 HR hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro], tty = SBD). Drug1 is resolved to hydrocodone, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Hydrocodone and Mirabegron.
Applies to: Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet <> Myrbetriq 25 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1300797, name = 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq], tty = SBD). Drug1 is resolved to valsartan, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Valsartan and Mirabegron. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to mirabegron and interaction asserted in DrugBank between Hydrochlorothiazide and Mirabegron.
Applies to: Testosterone 75 MG Drug Implant <> Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet
Drug1 (rxcui = 318240, name = testosterone 75 MG Drug Implant, tty = SCD). Drug2 (rxcui = 636045, name = hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet, tty = SCD). Drug1 is resolved to testosterone enanthate, Drug2 is resolved to valsartan and interaction asserted in DrugBank between Testosterone enanthate and Valsartan. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to testosterone undecanoate and interaction asserted in DrugBank between Hydrochlorothiazide and Testosterone undecanoate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to testosterone enanthate and interaction asserted in DrugBank between Hydrochlorothiazide and Testosterone enanthate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Hydrochlorothiazide and Testosterone cypionate. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to testosterone propionate and interaction asserted in DrugBank between Hydrochlorothiazide and Testosterone propionate. Drug1 is resolved to valsartan, Drug2 is resolved to testosterone cypionate and interaction asserted in DrugBank between Valsartan and Testosterone cypionate. Drug1 is resolved to testosterone undecanoate, Drug2 is resolved to valsartan and interaction asserted in DrugBank between Testosterone undecanoate and Valsartan. Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to testosterone and interaction asserted in DrugBank between Hydrochlorothiazide and Testosterone. Drug1 is resolved to testosterone, Drug2 is resolved to valsartan and interaction asserted in DrugBank between Testosterone and Valsartan.
Applies to: DULoxetine 30 MG Delayed Release Oral Capsule <> Zohydro ER 30 MG 12HR Extended Release Oral Capsule
Drug1 (rxcui = 596930, name = duloxetine 30 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 1860498, name = 12 HR hydrocodone bitartrate 30 MG Extended Release Oral Capsule [Zohydro], tty = SBD). Drug1 is resolved to hydrocodone, Drug2 is resolved to duloxetine and interaction asserted in DrugBank between Hydrocodone and Duloxetine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.